PCP
AZN icon

Proficio Capital Partners’s AstraZeneca AZN Stock Holding History

Proficio Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
+7,518
New +$1.41M 0.05% 165
2025
Q3 		– Sell
-10,386
Closed -$1.45M – 241
2025
Q2 		$1.45M Sell
10,386
-1
-0% -$140 0.09% 122
2025
Q1 		$1.53M Buy
10,387
+4,984
+92% +$721K 0.12% 94
2024
Q4 		$708K Buy
5,403
+299
+6% +$41.9K 0.06% 137
2024
Q3 		$795K Sell
5,104
-403
-7% -$65.1K 0.08% 111
2024
Q2 		$859K Sell
5,507
-50
-0.9% -$7.52K 0.09% 118
2024
Q1 		$753K Hold
5,557
– – 0.08% 134
2023
Q4 		$749K Sell
5,557
-46
-0.8% -$5.98K 0.09% 113
2023
Q3 		$759K Sell
5,603
-22
-0.4% -$3K 0.1% 106
2023
Q2 		$805K Sell
5,625
-52
-0.9% -$7.65K 0.11% 104
2023
Q1 		$788K Buy
+5,677
New +$764K 0.13% 102
2020
Q2 		– Sell
-4,594
Closed -$410K – 173
2020
Q1 		$410K Buy
+4,594
New +$432K 0.1% 93
2019
Q3 		– Sell
-872
Closed -$72K – 267
2019
Q2 		$72K Buy
872
+15
+2% +$1.18K 0.02% 275
2019
Q1 		$69K Sell
857
-714
-45% -$56.3K 0.02% 270
2018
Q4 		$119K Buy
1,571
+83
+6% +$6.48K 0.05% 151
2018
Q3 		$118K Sell
1,488
-13
-0.9% -$983 0.04% 182
2018
Q2 		$105K Buy
1,501
+14
+0.9% +$1.01K 0.04% 199
2018
Q1 		$104K Buy
1,487
+352
+31% +$24.4K 0.03% 204
2017
Q4 		$79K Buy
1,135
+55
+5% +$3.71K 0.03% 253
2017
Q3 		$73K Sell
1,080
-143
-12% -$9.03K 0.03% 308
2017
Q2 		$74K Sell
1,223
-1
-0.1% -$65 0.03% 309
2017
Q1 		$84K Buy
1,224
+857
+234% +$49.9K 0.04% 273
2016
Q4 		$20K Sell
367
-774
-68% -$43.9K 0.01% 437
2016
Q3 		$75K Sell
1,141
-243
-18% -$15.9K 0.04% 205
2016
Q2 		$95K Buy
1,384
+465
+51% +$27K 0.06% 181
2016
Q1 		$52K Buy
919
+665
+262% +$40K 0.04% 203
2015
Q4 		$17K Buy
+254
New +$16.7K 0.02% 208

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Proficio Capital Partners's AZN Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in AstraZeneca (AZN) in Q2 2026: 7,518 shares worth $1.43M. The stake represents 0.05% of the portfolio and ranks #165 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in AZN as recently as Q2 2025.

Proficio Capital Partners first reported a position in AZN in Q4 2015 and has held it in 27 quarters since. The position peaked at $1.53M in Q1 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Proficio Capital Partners held 7,518 shares of AstraZeneca worth $1.43M as of Q2 2026.
  • AstraZeneca was a new Proficio Capital Partners position in Q2 2026.
  • AstraZeneca made up 0.05% of Proficio Capital Partners's portfolio in Q2 2026, its #165 holding.
  • Proficio Capital Partners first reported a position in AstraZeneca in Q4 2015 and has held it in 27 quarters since.
  • Proficio Capital Partners's AstraZeneca position peaked at $1.53M in Q1 2025.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.